CENTOGENE Japan is the Japanese subsidiary of CENTOGENE, a Germany-based company with strong expertise in rare and neurodegenerative diseases.
By leveraging the CENTOGENE Biodatabank, a global repository of clinical and genetic data, together with multi-omics technologies such as whole-genome sequencing, whole-exome sequencing, RNA analysis, proteomics, and metabolomics, we support pharmaceutical companies across drug discovery and clinical development.
Our key areas of support include patient cohort identification, prevalence estimation, patient stratification, biomarker and therapeutic target discovery, natural history studies, real-world data utilization, clinical trial feasibility assessment, and the identification of potential countries, sites, and patients for clinical studies.
By combining genetic testing capabilities with an international healthcare professional network, we also help identify difficult-to-diagnose patients and potential clinical trial candidates, contributing to more efficient research and development and faster drug development in rare diseases.
In Japan, we aim to integrate CENTOGENE’s global data and analytical capabilities into domestic research and clinical development through collaboration with pharmaceutical companies, medical institutions, research organizations, and CROs.
Researched company/organisation type / マッチングご希望企業・機関のタイプ
Researched disease area / マッチングご希望の疾患領域
Researched Modality / マッチングご希望のモダリティ
Researched Technologies / マッチングご希望の技術
Service
CENTOGENE Translational & Clinical Solutions / CENTOGENE トランスレーショナル・臨床開発ソリューション
CENTOGENE provides genetic testing, multi-omics and R&D solutions backed by a Biodatabank of 1M+ patients. / CENTOGENEは、100万人超の患者データを有するBiodatabankを基盤に、遺伝学的検査、マルチオミクス解析・研究開発支援を提供しています。